Log In
Print this Print this

Anifrolumab (MEDI-546) (formerly MDX-1333)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionHuman mAb targeting type I interferon (IFN) receptor 1
Molecular Target Type I interferon (IFN) receptor 1
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today